In colorectal cancers, tumour‐specific gene alterations of EGFR, BRAF, ALK, KIT, PDGFR, HER2 and KRAS75, 76, 77 were detected via ctDNA‐based assays. This evidence concerns the gene ERBB2 and neoplasm.